M
Miroslav Backonja
Researcher at University of Wisconsin-Madison
Publications - 96
Citations - 12928
Miroslav Backonja is an academic researcher from University of Wisconsin-Madison. The author has contributed to research in topics: Neuropathic pain & Chronic pain. The author has an hindex of 36, co-authored 94 publications receiving 12026 citations. Previous affiliations of Miroslav Backonja include University of Washington.
Papers
More filters
Journal ArticleDOI
Pharmacologic management of neuropathic pain: evidence-based recommendations.
Robert H. Dworkin,Alec B. O'Connor,Miroslav Backonja,John T. Farrar,Nanna B. Finnerup,Troels S. Jensen,Eija Kalso,John D. Loeser,Christine Miaskowski,Turo Nurmikko,Russell K. Portenoy,Andrew S.C. Rice,Brett R. Stacey,Rolf-Detlef Treede,Dennis C. Turk,Mark S. Wallace +15 more
TL;DR: Patients with neuropathic pain are challenging to manage and evidence‐based clinical recommendations for pharmacologic management are needed, and medications should be individualized, considering side effects, potential beneficial or deleterious effects on comorbidities, and whether prompt onset of pain relief is necessary.
Journal ArticleDOI
Gabapentin for the Symptomatic Treatment of Painful Neuropathy in Patients With Diabetes Mellitus: A Randomized Controlled Trial
Miroslav Backonja,Ahmad Beydoun,Keith R. Edwards,Sherwyn Schwartz,Vivian Fonseca,Marykay Hes,L. LaMoreaux,Elizabeth A. Garofalo +7 more
TL;DR: Gabapentin monotherapy appears to be efficacious for the treatment of pain and sleep interference associated with diabetic peripheral neuropathy and exhibits positive effects on mood and quality of life.
Journal ArticleDOI
Advances in Neuropathic Pain: Diagnosis, Mechanisms, and Treatment Recommendations
Robert H. Dworkin,Miroslav Backonja,Michael C. Rowbotham,Robert R. Allen,Charles R. Argoff,Gary J. Bennett,M. Catherine Bushnell,John T. Farrar,Bradley S. Galer,Jennifer A. Haythornthwaite,David J. Hewitt,John D. Loeser,Mitchell B. Max,Mario Saltarelli,Kenneth E. Schmader,Christoph Stein,David R. Thompson,Dennis C. Turk,Mark S. Wallace,Linda R. Watkins,Sharon M. Weinstein +20 more
TL;DR: In this article, the authors describe current approaches to the diagnosis and assessment of neuropathic pain and discuss the results of recent research on its pathophysiologic mechanisms, and provide specific recommendations for use of these medications.
Journal ArticleDOI
NeuPSIG guidelines on neuropathic pain assessment
Maija Haanpää,Nadine Attal,Miroslav Backonja,Ralf Baron,Michael I. Bennett,Didier Bouhassira,Giorgio Cruccu,Per Hansson,Jennifer A. Haythornthwaite,Gian Domenico Iannetti,Troels S. Jensen,Timo Kauppila,Turo Nurmikko,Andew S C Rice,Michael C. Rowbotham,Jordi Serra,Claudia Sommer,Blair H. Smith,Rolf-Detlef Treede +18 more
TL;DR: Screening questionnaires are suitable for identifying potential patients with neuropathic pain, but further validation of them is needed for epidemiological purposes and quantitative sensory testing is recommended for selected cases in clinic, including the diagnosis of small fiber neuropathies and for research purposes.
Journal ArticleDOI
Recommendations for the management of herpes zoster.
Robert H. Dworkin,Robert W. Johnson,Judith Breuer,John W. Gnann,John W. Gnann,Myron J. Levin,Miroslav Backonja,Robert F. Betts,Anne A. Gershon,Maija Haanpää,M.W. McKendrick,Turo Nurmikko,Anne Louise Oaklander,Michael N. Oxman,Deborah Pavan-Langston,Karin L. Petersen,Michael C. Rowbotham,Kenneth E. Schmader,Brett R. Stacey,Stephen K. Tyring,Albert J.M. van Wijck,Mark S. Wallace,Sawko W. Wassilew,Richard J. Whitley +23 more
TL;DR: The results of controlled trials and the clinical experience of the authors support the use of acyclovir, brivudin (where available), famciclovir, and valacy Clovir as first-line antiviral therapy for the treatment of patients with HZ.